Ayala Pharmaceuticals Inc (ADXS)

[Donjayouworry]

Thoughts/ramblings; unraveling the unknown...

1. Senior executives are usually the ones let go when companies are trying to save money (very high Executive Pay and long-term Equity awards)...But Advaxis doesn't give a flying cluck about exec pay Equity dilution (or cashflow despite Bonstein's delusional drivel) so this really doesn't seem to me like a short term savings strategy.

2. Two of the Senior positions removed are critical for Advaxis as a an independent company particularly Regulatory VP and COO position. Removing them, and doing so all at once, appears to be a signal that either New Leadership (CEO wanting to build own team) or change in control is coming. The former (a CEO wanting his/her own team) wouldn't likely manifest as ALL five folks being removed. Frankly a CFO is a position that a CEO likes to have hiring input in as that working relationship is important (Bonstein was brought in by DOC)...If two or three were removed the idea that a new CEO is bringing some new people in seems more plausible than the entire team (unless DOC's hiring skills were as awful as his stock price prediction skills.) Petit preceded O'Connor at Advaxis and he is the Star.

3. Bonstein was given a retention bonus and is still there because they NEED A CFO right now (for all we know new retention bonuses have been given to Petit and Bonstein through September 2018...we won't find out until we see it filed months from now.)...

4. While the clinical hold seems to have more than one event on hold, the real critical event that was holding things up was the official passing of the 30MM shares - I think a partial buyout by Amgen (as predicted by Iggy) looks likely.